Study: Some physicians uninformed about approved uses of drugs

It's hard enough making sure the pharmaceutical companies don't find tricky ways to pitch physicians on off-label uses of their drugs. Apparently, that's not the only problem out there with off-label prescriptions in the medical suite. Some physicians actually don't know that some typical uses of a given drug haven't been approved by the FDA, according to a new study published in Pharmacoepidemiology and Drug Safety.

To examine this issue, researchers from the University of Chicago Medical Center surveyed 1,199 doctors on their prescribing patterns--including 599 primary-care physicians and 600 psychiatrists--in 2007 and 2008. They included 22 drug-indication pairs, ranging from drugs approved for on-label use to off-label use supported by medical evidence to off-label use typically considered ineffective.

The researchers found that doctors surveyed were only able to identify the FDA approval status of just over half of the 22 drug-indication pairs.

To learn more about this study:
- read this UPI piece

Related Article:
Federal prosecutors: Psychiatrist paid to tout off-label antidepressant use

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.